Plasma Adiponectin Concentrations in Non-pregnant, Normal and Overweight Pregnant Women

Overview

Journal J Perinat Med

Date 2007 Oct 9

PMID 17919116

Citations 43

Authors

Jyh Kae Nien

Shali Mazaki-Tovi

Roberto Romero

Offer Erez

Juan Pedro Kusanovic

Francesca Gotsch

Beth L Pineles

Ricardo Gomez

Samuel Edwin

Moshe Mazor

Jimmy Espinoza

Bo Hyun Yoon

Sonia S Hassan

Affiliations

Soon will be listed here.

Abstract

Aims: Adiponectin is an adipokine that has anti-diabetic, anti-atherogenic, anti-inflammatory and angiogenic properties. This hormone has been implicated in both the physiological adaptation to normal pregnancy and in obstetrical complications. The aims of this study were to determine normal maternal plasma concentrations of adiponectin throughout gestation and to explore the relationships between plasma adiponectin concentration, pregnancy, and maternal overweight.

Methods: A cross-sectional study was designed to include normal pregnant (normal weight and overweight; 11-42 weeks of gestation), and non-pregnant women. Plasma adiponectin concentration was determined by immunoassay. Non-parametric statistics were used for analysis.

Results: (1) Adiponectin was detectable in the plasma of all patients; (2) there was no significant differences in the median adiponectin concentration between pregnant and non-pregnant women; (3) plasma adiponectin concentrations were negatively correlated with gestational age only among normal weight pregnant women; and (4) overweight patients had significantly lower plasma adiponectin concentrations than normal weight women.

Conclusions: Consistent with the increased insulin resistance and weight gain that occur in pregnancy, adiponectin concentrations were negatively correlated with gestational age. The results of this study and the nomogram herein presented, can serve as the basis to explore the relationship between adiponectin and pregnancy complications and facilitate the clinical use of this important adipokine.

Citing Articles

Trophoblast-specific overexpression of adiponectin receptor 2 causes fetal growth restriction in pregnant mice.

Dumolt J, Rosario F, Barentsen K, Urschitz J, Powell T, Jansson T FASEB J. 2024; 38(19):e70100.

PMID: 39387608 PMC: 11508969. DOI: 10.1096/fj.202302143R.

Adiponectin receptor 1 regulates endometrial receptivity via the adenosine monophosphate‑activated protein kinase/E‑cadherin pathway.

Sarankhuu B, Jeon H, Jeong D, Park S, Kim T, Lee S Mol Med Rep. 2024; 30(4).

PMID: 39155876 PMC: 11350624. DOI: 10.3892/mmr.2024.13308.

Regulation of placental amino acid transport in health and disease.

Shimada H, Powell T, Jansson T Acta Physiol (Oxf). 2024; 240(7):e14157.

PMID: 38711335 PMC: 11162343. DOI: 10.1111/apha.14157.

Maternal Blood Adipokines and Their Association with Fetal Growth: A Meta-Analysis of the Current Literature.

Sapantzoglou I, Vlachos D, Papageorgiou D, Varthaliti A, Rodolaki K, Daskalaki M J Clin Med. 2024; 13(6).

PMID: 38541892 PMC: 10971104. DOI: 10.3390/jcm13061667.

Obesity in prenatal medicine: a game changer?.

Prodan N, Schmidt M, Hoopmann M, Abele H, Kagan K Arch Gynecol Obstet. 2023; 309(3):961-974.

PMID: 37861742 PMC: 10867045. DOI: 10.1007/s00404-023-07251-x.

References

Yu Y, Zhu H . Chronological changes in metabolism and functions of cultured adipocytes: a hypothesis for cell aging in mature adipocytes. Am J Physiol Endocrinol Metab. 2003; 286(3):E402-10. DOI: 10.1152/ajpendo.00247.2003. View

Worda C, Leipold H, Gruber C, Kautzky-Willer A, Knofler M, Bancher-Todesca D . Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol. 2004; 191(6):2120-4. DOI: 10.1016/j.ajog.2004.04.038. View

Catalano P . Management of obesity in pregnancy. Obstet Gynecol. 2007; 109(2 Pt 1):419-33. DOI: 10.1097/01.AOG.0000253311.44696.85. View

Lopez-Bermejo A, Fernandez-Real J, Garrido E, Rovira R, Brichs R, Genaro P . Maternal soluble tumour necrosis factor receptor type 2 (sTNFR2) and adiponectin are both related to blood pressure during gestation and infant's birthweight. Clin Endocrinol (Oxf). 2004; 61(5):544-52. DOI: 10.1111/j.1365-2265.2004.02120.x. View

Butte N, Wong W, Treuth M, Ellis K, OBrian Smith E . Energy requirements during pregnancy based on total energy expenditure and energy deposition. Am J Clin Nutr. 2004; 79(6):1078-87. DOI: 10.1093/ajcn/79.6.1078. View

Combs T, Berg A, Rajala M, Klebanov S, Iyengar P, Jimenez-Chillaron J . Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes. 2003; 52(2):268-76. DOI: 10.2337/diabetes.52.2.268. View

Gimeno R, Klaman L . Adipose tissue as an active endocrine organ: recent advances. Curr Opin Pharmacol. 2005; 5(2):122-8. DOI: 10.1016/j.coph.2005.01.006. View

Lu D, Yang X, Wu Y, Wang H, Huang H, Dong M . Serum adiponectin, leptin and soluble leptin receptor in pre-eclampsia. Int J Gynaecol Obstet. 2006; 95(2):121-6. DOI: 10.1016/j.ijgo.2006.06.015. View

Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J . Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257(1):79-83. DOI: 10.1006/bbrc.1999.0255. View

10.

Catalano P, Hoegh M, Minium J, Huston-Presley L, Bernard S, Kalhan S . Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia. 2006; 49(7):1677-85. DOI: 10.1007/s00125-006-0264-x. View

11.

McLachlan K, ONeal D, Jenkins A, Alford F . Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab Res Rev. 2005; 22(2):131-8. DOI: 10.1002/dmrr.591. View

12.

Berg A, Scherer P . Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005; 96(9):939-49. DOI: 10.1161/01.RES.0000163635.62927.34. View

13.

Yu J, Javorschi S, Hevener A, Kruszynska Y, Norman R, Sinha M . The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes. 2002; 51(10):2968-74. DOI: 10.2337/diabetes.51.10.2968. View

14.

Berg A, Combs T, Scherer P . ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 2002; 13(2):84-9. DOI: 10.1016/s1043-2760(01)00524-0. View

15.

Korner A, Wabitsch M, Seidel B, Fischer-Posovszky P, Berthold A, Stumvoll M . Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight. Biochem Biophys Res Commun. 2005; 337(2):540-50. DOI: 10.1016/j.bbrc.2005.09.064. View

16.

Engstrom B, Burman P, Holdstock C, Anders Karlsson F . Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients. J Clin Endocrinol Metab. 2003; 88(11):5193-8. DOI: 10.1210/jc.2003-030713. View

17.

Ronti T, Lupattelli G, Mannarino E . The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf). 2006; 64(4):355-65. DOI: 10.1111/j.1365-2265.2006.02474.x. View

18.

Pipe N, Smith T, Halliday D, Edmonds C, Williams C, Coltart T . Changes in fat, fat-free mass and body water in human normal pregnancy. Br J Obstet Gynaecol. 1979; 86(12):929-40. DOI: 10.1111/j.1471-0528.1979.tb11240.x. View

19.

Friedman J . Obesity in the new millennium. Nature. 2000; 404(6778):632-4. DOI: 10.1038/35007504. View

20.

Farvid M, Ng T, Chan D, Barrett P, Watts G . Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. Diabetes Obes Metab. 2005; 7(4):406-13. DOI: 10.1111/j.1463-1326.2004.00410.x. View